Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dexamethasone as a probe for docetaxel clearance.
Puisset F, Chatelut E, Dalenc F, Busi F, Cresteil T, Azéma J, Poublanc M, Hennebelle I, Lafont T, Chevreau C, Roché H. Puisset F, et al. Among authors: dalenc f. Cancer Chemother Pharmacol. 2004 Sep;54(3):265-72. doi: 10.1007/s00280-004-0823-0. Epub 2004 May 5. Cancer Chemother Pharmacol. 2004. PMID: 15133628 Clinical Trial.
Ototoxicity of high-dose carboplatin.
Chevreau C, Thomas F, Couteau C, Dalenc F, Mourey L, Chatelut E. Chevreau C, et al. Among authors: dalenc f. J Clin Oncol. 2005 May 20;23(15):3649-50; author reply 3650-1. doi: 10.1200/JCO.2005.05.348. J Clin Oncol. 2005. PMID: 15908692 No abstract available.
Dexamethasone as a probe for vinorelbine clearance.
Puisset F, Dalenc F, Chatelut E, Cresteil T, Lochon I, Tisnes P, Roché H. Puisset F, et al. Among authors: dalenc f. Br J Clin Pharmacol. 2005 Jul;60(1):45-53. doi: 10.1111/j.1365-2125.2005.02384.x. Br J Clin Pharmacol. 2005. PMID: 15963093 Free PMC article. Clinical Trial.
Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme.
Moyal EC, Laprie A, Delannes M, Poublanc M, Catalaa I, Dalenc F, Berchery D, Sabatier J, Bousquet P, De Porre P, Alaux B, Toulas C. Moyal EC, et al. Among authors: dalenc f. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1396-401. doi: 10.1016/j.ijrobp.2007.02.043. Epub 2007 Jun 14. Int J Radiat Oncol Biol Phys. 2007. PMID: 17570606 Clinical Trial.
[Pharmacological bases of intraperitoneal chemotherapy].
Gladieff L, Chatelut E, Dalenc F, Ferron G. Gladieff L, et al. Among authors: dalenc f. Bull Cancer. 2009 Dec;96(12):1235-42. doi: 10.1684/bdc.2009.0982. Bull Cancer. 2009. PMID: 19923051 Review. French.
Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis.
Dalenc F, Doisneau-Sixou SF, Allal BC, Marsili S, Lauwers-Cances V, Chaoui K, Schiltz O, Monsarrat B, Filleron T, Renée N, Malissein E, Meunier E, Favre G, Roché H. Dalenc F, et al. Clin Cancer Res. 2010 Feb 15;16(4):1264-71. doi: 10.1158/1078-0432.CCR-09-1192. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145184 Clinical Trial.
225 results